
Carlos del Rio
@carlosdelrio7
Chair Department of Medicine at Emory Univ SOM; co-Director Emory CFAR; International Secretary of NAM. Posted opinions are own. RT not endorsements.
ID: 451192624
https://med.emory.edu/departments/medicine/divisions/infectious-diseases/profile/?u=CDELRIO 31-12-2011 04:34:35
74,74K Tweet
55,55K Followers
1,1K Following


Honoring Excellence, Announcing New Members: Academy 2025 Election | American Academy of Arts and Sciences. Congratulations to my good friend Fadlo Khuri American University of Beirut on his election. amacad.org/news/new-membe…


The expanding universe of GLP-1 medicines-with dozens of new molecular entities in the clinic, how will they differentiate beyond #weightloss #obesity #diabetes #heartdiseasen Nature Reviews Drug Discovery nature.com/articles/s4157…




Impact of an international HIV funding crisis on HIV infections and mortality LMICs: a modelling study The Lancet HIV thelancet.com/journals/lanhi… A 24% ⬇️ in aid plus ending PEPFAR could cause an additional 4·43–10·75 M new HIV inf & 0·77–2·93 M deaths between 2025 & 2030.







Honored to have been invited by UCSF School of Medicine as the 2025Holly Smith Visiting Professor. medicine.ucsf.edu/about/faculty/…


🚨Final call for the 8th Annual Barbara Vick Impact Awards! Join us TOMORROW (5/29) at 5:30PM at Emory Public Health for a reception & ceremony to celebrate 23 #HIV advocates, service & care providers & researchers in Atlanta. Barbara Vick will be there! RSVP: bit.ly/2025BarbiesRSVP


What an honor to have Barbara Vick join us in person for the Emory CFAR CLC Impact Awards night.



NIH funding policy deals new blow to HIV-related trial networks Science Magazine It’s a mess, it’s wrong and unnecessary. science.org/content/articl…